Emerging research has consistently shown decreased circulating levels of SFRP5 and increased levels of Wnt5a in patients with CAD and obesity when compared to healthy controls (181, 182). This evidence concerns the gene SFRP5 and obesity due to melanocortin 4 receptor deficiency.